Propofol produces immobility via action in the ventral horn of the spinal cord by a GABAergic mechanism.
BACKGROUND
We investigated the actions of propofol and isoflurane on nociceptive responses of neurons in the spinal cord.


METHODS
We determined nociceptive responses of lumbar neurons in the dorsal horn (<1200 microm) and ventral horn (>1200 microm) of decerebrate rats before and during propofol (1 effective dose, ED(50)) or isoflurane (1 minimum alveolar concentration) anesthesia. During recording of ventral horn neurons, we administered picrotoxin by infusion to determine whether isoflurane and propofol differed in their effects at the gamma aminobutyric acid (GABA) Type A receptors. We also determined whether decerebration altered propofol requirements to produce immobility.


RESULTS
Decerebration did not affect propofol requirements. The ED(50) for propofol was 497 +/- 58 microg x kg(-1) x min(-1) in intact rats and 420 +/- 65 microg x kg(-1) x min(-1) in decerebrated rats (P > 0.05), with corresponding propofol blood concentrations of 8.1 +/- 1.1 microg/mL and 7.3 +/- 1.1 microg/mL, respectively (P > 0.05). Propofol did not significantly depress dorsal horn neurons, but isoflurane depressed the responses to 56% of control (P < 0.05). Propofol depressed ventral horn neurons to 47% of control, whereas isoflurane depressed ventral horn neurons to 20% of control. Picrotoxin significantly reversed the depressant effect of propofol on ventral horn neuronal responses (79% of control, not significantly different from control). Pic- rotoxin, however, had no effect on isoflurane's depression of ventral horn neuronal responses (26% of control).


CONCLUSIONS
Propofol acts in the spinal cord to produce immobility. This depressive effect occurs in the ventral horn and is mediated mainly by GABA(A) receptors. Isoflurane also depresses neurons in the ventral horn; however, isoflurane actions at the GABA(A) receptor are either weak or overridden by other effects in the ventral horn.
Department of Anesthesiology and Pain Medicine, University of California, Davis, California 95616, USA.
Gudrun
G
Kungys
Jongbun
J
Kim
Steven L
SL
Jinks
Richard J
RJ
Atherley
Joseph F
JF
Antognini
D000200:Action Potentials; D018685:Anesthetics, Inhalation / Q000008:administration & dosage; D018686:Anesthetics, Intravenous / Q000008:administration & dosage*; D000818:Animals; D000870:Anterior Horn Cells / Q000187:drug effects* / Q000378:metabolism; D003655:Decerebrate State; D018756:GABA Antagonists / Q000008:administration & dosage; D007103:Immobilization; D007530:Isoflurane / Q000008:administration & dosage; D008297:Male; D009068:Movement / Q000187:drug effects*; D017288:Pain Threshold / Q000187:drug effects; D010852:Picrotoxin / Q000008:administration & dosage; D020671:Posterior Horn Cells / Q000187:drug effects / Q000378:metabolism; D015742:Propofol / Q000008:administration & dosage*; D051381:Rats; D017207:Rats, Sprague-Dawley; D011963:Receptors, GABA-A / Q000187:drug effects / Q000378:metabolism; D005680:gamma-Aminobutyric Acid / Q000378:metabolism*
D018685:Anesthetics, Inhalation; D018686:Anesthetics, Intravenous; D018756:GABA Antagonists; D007530:Isoflurane; D010852:Picrotoxin; D015742:Propofol; D011963:Receptors, GABA-A; D005680:gamma-Aminobutyric Acid